Back
ASML Holding NV Vs. Apogee Therapeutics, Inc. Industry Stock Comparison
Buy
69
ASMLF
ASML Holding NV
Last Price:
$1,346.93
Seasonality Move:
1.44%
Sell
44
APGE
Apogee Therapeutics, Inc.
Last Price:
$84.40
Seasonality Move:
-11.77%
Buy
69
ASML Holding NV (ASMLF)
is a Buy
Is ASML Holding NV a Buy, Sell or Hold?
-
The current ASML Holding NV [ASMLF] share price is $1,346.93. The Score for ASMLF is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
ASMLF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Apogee Therapeutics, Inc. (APGE)
is a Sell
Is Apogee Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Apogee Therapeutics, Inc. [APGE] share price is $84.34. The Score for APGE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
APGE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ASMLF Stock Price Chart
What is ASML Holding NV's stock price today?
-
The ASML Holding NV share price today is $1,346.93Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASMLF is experiencing buying pressure, which is a positive indicator for future bullish movement.
APGE Stock Price Chart
What is Apogee Therapeutics, Inc.'s stock price today?
-
The Apogee Therapeutics, Inc. share price today is $84.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APGE is experiencing buying pressure, which is a positive indicator for future bullish movement.
ASMLF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 294.63 | Buy |
| Relative Strength Index (14 RSI): | 48.66 | Sell |
| Chaikin Money Flow: | 202 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1317.12 - 1402.96) | Sell |
| Bollinger Bands (100): | (1089.2 - 1417.58) | Buy |
APGE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.18 | Buy |
| Relative Strength Index (14 RSI): | 64.96 | Buy |
| Chaikin Money Flow: | 432550 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.1 - 79.44) | Buy |
| Bollinger Bands (100): | (66.23 - 78.47) | Buy |
ASMLF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1339.14 | Buy |
| 20-day SMA: | 1350.9 | Sell |
| 50-day SMA: | 1395.02 | Sell |
| 200-day SMA: | 1051.98 | Buy |
| 8-day EMA: | 1312.7 | Buy |
| 20-day EMA: | 1073.29 | Buy |
| 50-day EMA: | 637.52 | Buy |
| 200-day EMA: | 199.7 | Buy |
APGE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 79.91 | Buy |
| 20-day SMA: | 75.21 | Buy |
| 50-day SMA: | 71.36 | Buy |
| 200-day SMA: | 57.28 | Buy |
| 8-day EMA: | 80.37 | Buy |
| 20-day EMA: | 76.41 | Buy |
| 50-day EMA: | 73.33 | Buy |
| 200-day EMA: | 61.58 | Buy |
ASML Holding NV Earnings Growth & ASMLF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apogee Therapeutics, Inc. Earnings Growth & APGE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.62 per share.
ASML Holding NV Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apogee Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||